About Sovereign Pharma
Sovereign Pharma is a company based in Daman (India) founded in 2004. The company has 638 employees. Sovereign Pharma offers products and services including Injectables and Diluents.
- Headquarter Daman, India
- Employees 638
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn
- Legal Name Sovereign Pharma Pvt. Ltd
- Date of Incorporation 28 May, 2003
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹142 Cr
FY 2025 · +15% YoY
- Net Profit₹17.60 Cr
FY 2025 · 12% margin
- EBITDA₹32.21 Cr
FY 2025 · 23% margin
- Employee Count638
Associated legal entities of Sovereign Pharma
Sovereign Pharma operates through Sovereign Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sovereign Pharma Private Limited CIN U24232MH2003PTC427275 | Active | 28 May 2003 | Mumbai, Maharashtra | ₹142 Cr | 638 | 9 | View details |
Products & Services of Sovereign Pharma
Sovereign Pharma offers a comprehensive portfolio of products and services, including Injectables and Diluents.
Terminally sterilized and aseptically filled injectables are manufactured for global supply
Sterile water for injection and sodium chloride injection are supplied to vaccine manufacturers
Board of directors of Sovereign Pharma Private Limited (Sovereign Pharma)
Sovereign Pharma Private Limited is the primary company behind Sovereign Pharma. The board of Sovereign Pharma Private Limited currently have 8 directors; the longest-serving is Kairus Shavak Dadachanji, appointed in 2003. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kairus Shavak Dadachanji DIN 00196582 | Managing Director | 28 May 2003 | 23 yrs 4 mo | Sovereign Pharma Private Limited |
| Cyrus Soli Poonawalla DIN 00044650 | Director | 28 May 2003 | 23 yrs 4 mo | Sovereign Pharma Private Limited |
| Shapoorji Pallonji Mistry DIN 00010114 | Director | 28 May 2003 | 23 yrs 4 mo | Sovereign Pharma Private Limited |
| Satish Hanumant Deshpande DIN 00055807 | Director | 28 May 2003 | 23 yrs 4 mo | Sovereign Pharma Private Limited |
| Adar Cyrus Poonawalla DIN 00044815 | Director | 28 May 2003 | 23 yrs 4 mo | Sovereign Pharma Private Limited |
| Rishad Kairus Dadachanji DIN 06882522 | Director | 01 Oct 2021 | 5 yrs | Sovereign Pharma Private Limited |
| Piyush Vinodrai Desai DIN 03178881 | Whole-time director | 01 Dec 2021 | 4 yrs 10 mo | Sovereign Pharma Private Limited |
| Makarand Shrikrishna Karkare DIN 00055908 | Director | 01 Dec 2021 | 4 yrs 10 mo | Sovereign Pharma Private Limited |
Financials of Sovereign Pharma
Figures of Sovereign Pharma Private Limited, the primary company behind Sovereign Pharma, for FY 2025. Revenue was ₹142 Cr (+15% year on year). Net profit was ₹17.60 Cr (12% margin). EBITDA was ₹32.21 Cr (23% margin). Revenue has grown at a compounded annual rate of +7% over three years and +8% over five years.
- ₹142 CrRevenue · FY 2025 · +15% YoY
- ₹17.60 CrNet profit · 12% margin
- ₹32.21 CrEBITDA · 23% margin
- ₹98.00 CrPaid-up capital
- 638Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sovereign Pharma Private Limited are on its company page.
Detailed financial statements for Sovereign Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Sovereign Pharma
10 companies that operate in the same segment as Sovereign Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sovereign Pharma
Sovereign Pharma was founded in 2004.
Sovereign Pharma is headquartered in Daman, India. It is registered at Daman, Dadra And Nagar Haveli And Daman And Diu, India.
Sovereign Pharma has 638 employees.
The primary company behind Sovereign Pharma, Sovereign Pharma Private Limited, reported revenue of ₹142 Cr for FY 2025, up 15% year on year.
Sovereign Pharma is identified as a contract manufacturing organization that was established in 2003 under the Dadachanji Group. It is recognized for its WHO-GMP Geneva certified facility, where over 1 billion injection doses are produced annually for terminally sterilized and aseptically filled injectables. Products such as diluents are supplied globally to major vaccine manufacturers and organizations like WHO, UNICEF, and PAHO. Deliveries are made to more than 50 countries, supporting various health initiatives. The companys operations are noted for their quality focus and extensive experience in the field.
Sovereign Pharma offers Injectables and Diluents.
Sovereign Pharma operates through Sovereign Pharma Private Limited.
The legal entities of Sovereign Pharma currently have 9 directors, including Kairus Shavak Dadachanji, Cyrus Soli Poonawalla, Shapoorji Pallonji Mistry and others.